CVS HEALTH CORPORATION (CVS) FY2025 YTD Q2 P&L / Income Statement
2025-01-01 to 2025-06-30
Revenue by Product and Service
2025-01-01 to 2025-06-30
Swipe to see the full flow
Chart details
CVS HEALTH CORPORATION (CVS) FY2025 YTD Q2 P&L / Income Statement
Income statement for 2025-01-01 through 2025-06-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenues
- 193,503,000,000 US dollars
- Total operating costs
- 187,748,000,000 US dollars
- Operating income
- 5,755,000,000 US dollars
- Other income (expense), net (calculated)
- negative 1,491,000,000 US dollars
- Income before income tax provision
- 4,264,000,000 US dollars
- Income tax provision
- 1,469,000,000 US dollars
- Net income
- 2,795,000,000 US dollars
- Products
- 118,276,000,000 US dollars
- Services
- 7,205,000,000 US dollars
- Premiums
- 67,015,000,000 US dollars
- Net investment income
- 1,007,000,000 US dollars
- Cost of products sold
- 105,062,000,000 US dollars
- Health care costs
- 60,452,000,000 US dollars
- Operating expenses
- 22,234,000,000 US dollars
Chart connections
- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $2.80 B; to noncontrolling interests: −$5.00 M.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Operating margin
3.0%
Operating profit / revenue
Cash conversion
230.9%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
